文献速递脑血管病外科神经重症

CTA与DSA作为非创伤性蛛网膜下腔出血首选诊断工具的成本效果分析

Computed Tomography Angiography versus Digital Subtraction Angiography as a Primary Diagnostic Tool in Nontraumatic Subarachnoid Hemorrhage: Cost-Effectiveness Analysis Study.
PubMed 文献 · World Neurosurg · 2021-05-29

本研究通过决策分析模型模拟非创伤性蛛网膜下腔出血患者以DSA或CTA作为首选诊断工具的成本效果。基础病例计算显示,以DSA为首选工具成本低1261.82美元且多获得0.0001质量调整生命年。概率敏感性分析中DSA在超过65%的迭代中具有成本效果。确定性敏感性分析显示,当血管内治疗使用概率>47.2%时DSA更优,否则CTA更优;当DSA成本>2.6倍CTA+600美元时CTA更优。

要点

  • 基础病例中DSA作为首选诊断工具成本低1261.82美元且多获得0.0001 QALY。
  • 概率敏感性分析中DSA在超过65%的迭代中具有成本效果。
  • 血管内治疗概率>47.2%时DSA更优,否则CTA更优。

核心结论

  • 基于当前文献和模型,DSA作为非创伤性SAH病因的首选诊断工具更具成本效果。
  • 临床实践中可根据本中心血管内手术规模及CTA与DSA的成本关系选择DSA或CTA。

研究设计与样本

  • 构建决策分析模型模拟非创伤性SAH患者以DSA或CTA作为首选诊断工具。
  • 模型输入数据提取自文献,并进行概率性和确定性敏感性分析以评估模型稳健性。

主要发现

  • 基础病例计算中,以DSA为首选诊断工具成本低1261.82美元且多获得0.0001 QALY。
  • 概率敏感性分析中,选择DSA作为首选工具在超过65%的迭代中具有成本效果。
  • 确定性敏感性分析显示,当血管内治疗使用概率>47.2%时选择DSA更具成本效果,否则CTA更优。
  • 当DSA成本>2.6×CTA+600美元时,CTA更具成本效果。

临床怎么用

  • 临床医生可根据本中心血管内手术规模选择DSA或CTA作为非创伤性SAH的首选诊断工具。
  • 临床医生可根据本机构CTA与DSA的成本关系选择首选诊断工具。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Digital subtraction angiography (DSA) and computed tomographic angiography (CTA) are used to identify the cause of nontraumatic subarachnoid hemorrhage (SAH). There is no consensus on which to choose as the first diagnostic tool. We aimed to compare the cost-effectiveness of CTA versus DSA as a primary tool for identifying the cause of nontraumatic SAH. METHODS: A decision analysis model was built to simulate patients undergoing DSA or CTA as a primary diagnostic tool for the cause of nontraumatic SAH. The input data for the study were extracted from literature. Probabilistic and deterministic sensitivity analyses were performed to evaluate the robustness of the model. RESULTS: In the base case calculation, it cost $1261.82 less and yielded 0.0001 quality-adjusted life year (QALY) when DSA was used as a primary diagnostic imaging tool for nontraumatic SAH. Choosing DSA as a primary tool was cost-effective in more than 65% of iterations in probabilistic sensitivity analysis. Deterministic sensitivity analyses show when the probability of using endovascular treatment is >47.2%, choosing DSA is more cost-effective; otherwise, CTA is more optimal. CTA is more cost-effective when the cost for DSA >2.6 × CTA + $600. CONCLUSIONS: Based on current literature and our model DSA as a primary diagnostic tool for the cause of nontraumatic SAH is more cost-effective. However, in clinical practice physicians can choose either DSA or CTA according to the scale of endovascular procedures used in their center, as well as the cost correlation between CTA and DSA, which varies among institutions.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Salih M, Moore JM, Ogilvy CS, et al. Computed Tomography Angiography versus Digital Subtraction Angiography as a Primary Diagnostic Tool in Nontraumatic Subarachnoid Hemorrhage: Cost-Effectiveness Analysis Study. World Neurosurg. 2021. PMID: 34062303. doi:10.1016/j.wneu.2021.05.103

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。